Evaluation of apramycin activity against methicillin-resistant, methicillin-sensitive, and vancomycin-intermediate Staphylococcus aureus clinical isolates
Authors:
- 1 October 2018
- journal article
- research article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 92 (2) , 168-171
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Dissociation of antibacterial activity and aminoglycoside ototoxicity in the 4-monosubstituted 2-deoxystreptamine apramycinProceedings of the National Academy of Sciences, 2012
- Novel Apramycin Resistance Gene apmA in Bovine and Porcine Methicillin-Resistant Staphylococcus aureus ST398 IsolatesAntimicrobial Agents and Chemotherapy, 2011
- Community-associated meticillin-resistant Staphylococcus aureusThe Lancet, 2010
- Vancomycin-Associated Nephrotoxicity: Grave Concern or Death by Character Assassination?The American Journal of Medicine, 2010
- Clinical failures of appropriately-treated methicillin-resistant Staphylococcus aureus infectionsJournal of Infection, 2008
- Larger Vancomycin Doses (at Least Four Grams per Day) Are Associated with an Increased Incidence of NephrotoxicityAntimicrobial Agents and Chemotherapy, 2008
- Setting and Revising Antibacterial Susceptibility BreakpointsClinical Microbiology Reviews, 2007
- Comparative Pharmacodynamics of Gentamicin against Staphylococcus aureus and Pseudomonas aeruginosaAntimicrobial Agents and Chemotherapy, 2006
- Serum and milk concentrations of apramycin in lactating cows, ewes and goatsJournal of Veterinary Pharmacology and Therapeutics, 1995
- Clinical pharmacology of apramycin in calvesJournal of Veterinary Pharmacology and Therapeutics, 1985